Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

INFECTIOUS DISEASES SOCIETY OF AMERICA

Filed by ARENTFOX SCHIFF LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 18, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
02f0cf3a-2030-464b-9ace-1015e4a84715
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill

Literal federal measure citations: H.R.7352, S. 4875

BUD · Budget/Appropriations

H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026)

Literal federal measure citations: H.R. 9260, H.R. 4445, S.4283

MMM · Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies Calendar Year 2027 Physician Fee Schedule

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.